Germany: BioNTech shutting down COVID vaccine production entirely, 1,860 jobs at risk

The German company that pioneered one of the first mRNA coronavirus vaccines is halting production, handing the reins to partner Pfizer. BioNTech is restructuring to focus on research and illnesses like cancer.

Leave a Reply

Your email address will not be published. Required fields are marked *